Revive Therapeutics buys DiagnaMed’s molecular hydrogen intellectual property
The research has been focusing on the incurable disease known as ALS.
The post Revive Therapeutics buys DiagnaMed’s molecular hydrogen intellectual property appeared first on Green Market Report.
